ライフサイエンスコーパス: Netherlands

1 n Achieva MRI 3T device (Philips, Amsterdam, Netherlands).

2 rom two large datasets, UPDB (US) and LINKS (Netherlands).

3 ence of Asthma and Mite Allergy (PIAMA) (The Netherlands).

4 ) and Janssen Vaccines & Prevention (Leiden, Netherlands).

5 an from the original release location in the Netherlands.

6 ften low in Italy and most often high in the Netherlands.

7 nter randomised trial in 15 hospitals in the Netherlands.

8 und 1890 (1845-1925) and originated from the Netherlands.

9 l found off the present-day coastline of The Netherlands.

10 vaccination in a high-risk population in the Netherlands.

11 lticenter randomized controlled trial in the Netherlands.

12 actors for sporadic cryptosporidiosis in the Netherlands.

13 olled trial (IMAGINE) in 11 hospitals in the Netherlands.

14 in 6635 kidney transplants performed in The Netherlands.

15 2014 and 2015 at 61 residential sites in The Netherlands.

16 eaching hospitals in Belgium, Italy, and the Netherlands.

17 servational, multicenter cohort study in The Netherlands.

18 urse ratios and in-hospital mortality in The Netherlands.

19 AI) viruses in wild birds and poultry in the Netherlands.

20 inform public health decision-making in the Netherlands.

21 after analysis in a teaching hospital in the Netherlands.

22 anobacterial mats on coral reefs in Bonaire, Netherlands.

23 8,470 controls from Denmark, Iceland and the Netherlands.

24 er and Gastrointestinal Research, Rotterdam, Netherlands.

25 ospitals in the USA, France, the UK, and the Netherlands.

26 trol local transmission of SARS-CoV-2 in the Netherlands.

27 rge nonacademic hospitals in New York or the Netherlands.

28 ormed at 2 university medical centers in the Netherlands.

29 longitudinal birth cohort in Rotterdam, the Netherlands.

30 xed ICUs of 2 tertiary care hospitals in the Netherlands.

31 admissions from 2 tertiary hospitals in the Netherlands.

32 Three large tertiary care ICUs in the Netherlands.

33 cancer during the introduction of MIG in the Netherlands.

34 l ICU of two large teaching hospitals in the Netherlands.

35 r treatment for acute ischemic stroke in the Netherlands.

36 e ICUs of two tertiary care hospitals in the Netherlands.

37 general, nonfarming, rural population in the Netherlands.

38 Two tertiary mixed ICUs in The Netherlands.

39 in 16 multidisciplinary pain clinics in the Netherlands.

40 2014 through October 2015 in Maastricht, The Netherlands.

41 eration R, a prospective birth cohort in the Netherlands.

42 thin eight gynecologic cancer centers in the Netherlands.

43 ary and tertiary care centers throughout the Netherlands.

44 t academic and non-academic hospitals in the Netherlands.

45 nits following alerts in Switzerland and The Netherlands.

46 d lifestyle programs, in 15 hospitals in the Netherlands.

47 astrectomy in three bariatric centers in the Netherlands.

48 16 hospitals in the Netherlands.

49 tiary dry eye clinic patient cohort from the Netherlands.

50 cs of CDI among hospitalized children in the Netherlands.

51 C-Sophia Children's Hospital, Rotterdam, the Netherlands.

52 e use of MIG increased from 4% to 53% in the Netherlands.

53 , and development of PCP cooperatives in the Netherlands.

54 the largest health insurance provider in the Netherlands.

55 University hospital in the Netherlands.

56 ast cancer cases and 2,327 controls from the Netherlands.

57 (cc11) was observed from October 2015 in the Netherlands.

58 in, and later also outside, the south of the Netherlands.

59 udy at eight sites in France, Italy, and the Netherlands.

60 , from Sweden via Norway, to Denmark, to the Netherlands.

61 ate a regional background spatial map of the Netherlands.

62 gastrectomy (SG) in Sweden, Norway, and the Netherlands.

63 brane endothelial keratoplasty (DMEK) in the Netherlands.

64 many, Ireland, Spain, Italy, Denmark and the Netherlands.

65 uding the UK, US, Australia, Canada, and the Netherlands.

66 DS as BTS for LSOCC has been observed in the Netherlands.

67 hy were enrolled in 6 corneal centers in The Netherlands.

68 Maastricht University Medical Center+ in the Netherlands."

69 ial Science at the Lorentz Center in Leiden, Netherlands, 16-20 July 2018.

70 egnancy cohorts (the Generation R Study, the Netherlands 2002-2006 [n = 4,682]) and the Born in Bradf

71 In a population-based cohort in The Netherlands (2002-2006), we calculated polygenic risk sc

72 opulation-based birth cohort from Rotterdam, Netherlands (2002-2006).

73 the National Food Consumption Survey in the Netherlands (2007-2010) to form a baseline, we used quad

74 ata from the Rotterdam Study (Rotterdam, the Netherlands, 2009-2013) to demonstrate how confusion can

75 s with immunity propagation to data from the Netherlands (2012-2017).

76 -shift workers from the Klokwerk+ Study (the Netherlands, 2016-2017) registered the occurrence of ILI

77 years, 55% female) from 36 studies from the Netherlands, 471,759 people (40-69 years, 55.5% female)

78 ctive cohort study ongoing since 1989 in the Netherlands, 5,273 dementia-free participants (58.1% wom

79 th the highest rates in Italy (9.3%) and the Netherlands (7.4%) and the lowest rates in South Korea (

80 an self-efficacy score >5 was highest in the Netherlands (76.4%), ranged between 55.9% and 60.0% in B

81 y after esophagectomy and gastrectomy in the Netherlands according to the definitions of the Esophage

82 Funded by the Dutch Postcode Lottery in the Netherlands, Alexander von Humboldt-Stiftung (Humboldt-S

83 019, in 8 intensive care units (ICUs) in the Netherlands among 980 patients without ARDS expected not

84 ormed in a tertiary center in Amsterdam, the Netherlands, among adult patients scheduled for elective

85 ackground locations (3 x 2 weeks) across the Netherlands and a reference site continuously over a tot

86 ported from January 2015 to June 2018 in the Netherlands and assessed clinical manifestation and symp

87 %) were done in the UK, two (5%) each in the Netherlands and Australia, and one (2%) each in Switzerl

88 d in 19 neonatal intensive care units in the Netherlands and Belgium from November 15, 2011, to Decem

89 ugh linkages with national registries in the Netherlands and Belgium, and a review committee confirme

90 In 9 neonatal intensive care units in the Netherlands and Belgium, fecal samples of preterm infant

91 and adolescents with cerebral palsy from the Netherlands and Canada.

92 from two tertiary referral hospitals in the Netherlands and Canada.

93 ons between the serogroup W outbreaks in the Netherlands and England, and the historical serogroup C

94 outbreak of influenza A(H5N8) viruses in the Netherlands and Europe was more virulent; the number of

95 ding to the ECCG platform is feasible in the Netherlands and facilitates international benchmarking.

96 arge peripheral or academic hospitals in The Netherlands and followed for at least one year.

97 population-based cohorts of elderly from the Netherlands and Germany (n = 13,044).

98 eeded for public health interventions in the Netherlands and other affected countries to prevent furt

99 ies in Belgium, England, Finland, Italy, the Netherlands and Poland (n = 290).

100 rier along their migration route between The Netherlands and sub-Saharan Africa, is correlated with t

101 countries (Belgium, Switzerland, France, the Netherlands and the United Kingdom) and estimated the he

102 ntries (Bulgaria, Greece, Norway, Spain, the Netherlands and the United Kingdom) participated in the

103 55 years of age or older from the RS-I (The Netherlands) and 550 French adults 73 years of age or ol

104 om 0.60 for Ireland and UK, and 0.85 for the Netherlands) and also to detect gastrointestinal syndrom

105 nner (Elition, Philips Healthcare, Best, the Netherlands) and compared with 15 healthy volunteers (30

106 re derived from the PHARMO database network (Netherlands) and linked to patients diagnosed with colon

107 gh the HCHWA-D patient association (Katwijk, Netherlands) and the outpatient clinic of the Department

108 ective ALS registers (Ireland, Italy and the Netherlands), and clinical data sets in the UK and Belgi

109 he Leiden University Medical Center (Leiden, Netherlands), and healthy controls.

110 the STI outpatient clinic in Amsterdam, the Netherlands, and analyzed their cervicovaginal samples a

111 9, 2006, to April 26, 2013, in Nijmegen, the Netherlands, and Cologne, Germany.

112 nited Kingdom, Ireland, Germany, France, the Netherlands, and Denmark as most affected countries.

113 nts in MLH1, MSH2, or MSH6 from Germany, the Netherlands, and Finland who received at least 2 surveil

114 previous pet rat infections in England, the Netherlands, and France.

115 stralia, Italy, the USA, the UK, Canada, the Netherlands, and New Zealand, we recruited infants of le

116 d University Medical Center in Nijmegen, The Netherlands, and on ten transplant biopsies from an exte

117 tre trial (11 sites in Finland, Germany, the Netherlands, and Sweden), with optional 12-month double-

118 Finland, Norway, Canada, Poland, UK, Spain, Netherlands, and Sweden).

119 rom three academic hospitals in Belgium, the Netherlands, and the UK with locally advanced or metasta

120 ademic centres in France, Italy, Greece, the Netherlands, and the UK, and eight academic centres in t

121 d and neck treatment centres in Ireland, the Netherlands, and the UK, in patients aged 18 years or ol

122 dical centres) in Canada, France, Italy, the Netherlands, and the UK.

123 K. compared to three other countries (China, Netherlands, and the United States), which are primarily

124 3 hospitals in Belgium, Denmark, France, the Netherlands, and the United States, and follow-up was co

125 ompared with digital mammography (DM) in the Netherlands, and to quantify the uncertainty.Materials a

126 ian paramyxovirus serotype 3 (APMV-3) strain Netherlands as a safe vaccine vector against HPAIV, whic

127 National Institute for Public Health of the Netherlands asked a group of radiology and vascular medi

128 btained from the ethical review board of the Netherlands Association for Medical Education.

129 eing carried out in the southern part of the Netherlands (baseline data assessment, November 2010-Jan

130 No LPD had been performed in the Netherlands before this study.

131 ossBoss and Hybrid Procedures in France, the Netherlands, Belgium and United Kingdom) aims to evaluat

132 ossBoss and Hybrid Procedures in France, the Netherlands, Belgium and United Kingdom, RECHARGE regist

133 way, Denmark, Iceland, Ireland, England, the Netherlands, Belgium, Germany (Hesse), Malta, the United

134 patients diagnosed with primary TGCT in the Netherlands between 1989 and 2007.

135 cute HF were enrolled in 14 hospitals in the Netherlands between 2009 and 2014.

136 ls were recruited in Ireland, Italy, and the Netherlands between 2010 and 2015.

137 primary repairs of degenerative AAAs in the Netherlands between 2016 and 2018 in which the shape was

138 is to two intensive care units (ICUs) in the Netherlands between Jan 1, 2011, and July 20, 2012 (disc

139 ll transplanted and discarded kidneys in the Netherlands between January 1, 2000, and December 31, 20

140 All ICUs in the Netherlands between January 2009 and 2014 that participa

141 to two tertiary intensive care units in the Netherlands between January 2011 and June 2013, a total

142 proach was implemented in 6 hospitals in The Netherlands between January 2016 and January 2018.

143 e admitted to the ICUs of 4 hospitals in the Netherlands between March 23 and April 12, 2020.

144 Neuroscience at Maastricht University in the Netherlands between May 20, 2019, and March 27, 2020.

145 Subjects were recruited in the Netherlands between November 2014 and July 2016.

146 al age recruited from 8 hospitals across the Netherlands between October 2015 and October 2017, with

147 people aged 40-69 years (50-69 years in the Netherlands), between April, 2001, and December, 2006, i

148 bdominal Wall and Groin Pain, Eindhoven, The Netherlands, between June 1, 2011 and September 1, 2016.

149 12, cryptosporidiosis cases increased in the Netherlands, but no single source was identified.

150 The Netherlands Cancer Registry database (2005-2013) identif

151 FIT screening, the cohort was linked to the Netherlands Cancer Registry, through March 31, 2015; par

152 etween 2010 and 2016, were selected from the Netherlands Cancer Registry.

153 articipating hospitals was obtained from the Netherlands Cancer Registry; the hospitals were then cla

154 EMBO, Wellcome Trust, EU, AHA, ACClinPharm, Netherlands CVRI, Dutch Heart Foundation, Dutch Federati

155 In Belgium and the Netherlands, DCDs were responsible for 30% of deceased d

156 ountries (USA, France, Italy, UK, Spain, the Netherlands, Denmark, Israel, Switzerland, and Germany).

157 anic, 11 pasture and 10 conventional) in the Netherlands, during winter and summer.

158 t 5 centers in United States and 1 center in Netherlands enrolled in the Barrett's Esophagus Study da

159 domized controlled, multicenter trial in the Netherlands, enrolling patients with ST-segment-elevatio

160 population-based birth cohort in Rotterdam, Netherlands (enrollment 2002-2006).

161 overy and replication design embedded in the Netherlands Epidemiology of Obesity (NEO) study.

162 Participants of the NEO (Netherlands Epidemiology of Obesity) study (n=5630) cons

163 search Council Australia, KindreneKankervrij Netherlands, European Union Seventh Framework Programme,

164 linical trial conducted in Isala Zwolle, the Netherlands (February 2011-January 2015), involving pati

165 from 8 countries (United Kingdom, Spain, The Netherlands, Finland, Japan, Brazil, South Africa, and A

166 alibrated model for OxRec can be used in the Netherlands for individuals released from prison and ind

167 at Wilhelmina Children's Hospital (Utrecht, Netherlands) for a WHO-defined LRTI requiring mechanical

168 ospective (n = 102) stool specimens from The Netherlands, France, and Switzerland were tested on the

169 n temperate countries, such as Italy, Spain, Netherlands, France, England and Belgium.

170 eptic shock in 2 intensive care units in the Netherlands from 2011 to 2015.

171 The relative increase in the Netherlands from 2014-15 to 2015-16 was 418% (95% CI 99-

172 g to Rome IV criteria) at 4 hospitals in The Netherlands from August 2016 through March 2018; 189 pat

173 o the Rome III criteria, at hospitals in The Netherlands from December 2009 to May 2014.

174 ic general surgery at a single center in the Netherlands from May to November, 2017 was conducted.

175 countries (Canada, France, England, and the Netherlands) from which data were collected from January

176 prised all persons with CRC diagnosed in the Netherlands general population during the same period, i

177 ients, insurers, and policy makers) from the Netherlands, Germany, the United Kingdom, Ireland, Hunga

178 amples originating from Germany, Poland, the Netherlands, Greece, Spain, China and Peru was determine

179 Denmark and the Netherlands had the lowest PAF (0.0% each), while Cyprus

180 BioMolecular Research Infrastructure of the Netherlands has constructed an atlas of drug-metabolite

181 Other key members within the Netherlands Heart Institute are Peter van Tintelen on PL

182 Doevendans (Netherlands Heart Institute/UMC Utrecht NL) in Europe.

183 studies in the United Kingdom (EMBRACE), the Netherlands (HEBON), and France (GENEPSO).

184 a A(H5N8) viruses were first detected in the Netherlands in 2014 and caused five outbreaks in poultry

185 eristics of the cohort of NS patients in the Netherlands in order to identify whether potential immun

186 Stiftung), the Embassy of the Kingdom of the Netherlands in South Africa/Mozambique, British Columbia

187 In the Netherlands incidence of the disease increased despite i

188 elow the willingness-to-pay threshold in the Netherlands, indicating interval CRS and HIPEC is cost e

189 r Artisan Toric (Ophtec B.V., Groningen, The Netherlands) iris-fixated pIOL for the treatment of myop

190 General for International Cooperation of the Netherlands, Irish Aid, Australia Department of Foreign

191 xpansion of the MenW:cc11 2013 strain in the Netherlands, its high case fatality, and the availabilit

192 Netherlands Lung Foundation, Erasmus MC, Farr Institute,

193 inistry of Health, Medecins Sans Frontieres, Netherlands Ministry of Health, Welfare and Sport, and U

194 n a genetically isolated population from the Netherlands (n = 1999).

195 e Erasmus Medical Center (validation) in the Netherlands (n = 403; median age, 24.2 years [range, 18.

196 the United States, Canada, Denmark, and The Netherlands (n = 6,271), we show that individuals who sp

197 tions in the United States (n = 352) and the Netherlands (n = 81).

198 tries (Austria, Germany, Greece, Latvia, the Netherlands [n = 3], Spain, Slovenia, United Kingdom [n

199 ology, and End Results (SEER)-18 Program and Netherlands National Cancer Registry (NCR) were analyzed

200 In this study (Netherlands National Trial Register #7085), we report th

201 Netherlands National Trial Register Identifier: NTR2768.

202 The Netherlands National Trial Register NTR4022.

203 The objective of the prospective CYPTAM (The Netherlands National Trial Register: NTR1509) study was

204 The Netherlands National Trials Registry, Number: NTR7072.

205 ited from centres in Australia, Ireland, the Netherlands, New Zealand, and the UK.

206 ritical care units in the United States, the Netherlands, New Zealand, Australia, and Saudi Arabia.

207 Greece, India, Ireland, Italy, Japan, Malta, Netherlands, New Zealand, Norway, Slovenia, United Kingd

208 a, Chile, Colombia, France, Germany, Israel, Netherlands, New Zealand, Norway, Spain, Sweden, UK, and

209 ce data from the United Kingdom (UK) and the Netherlands (NL), we demonstrate a simple and predictabl

210 professional football clubs in England, the Netherlands, Norway, and Portugal.

211 e), Amsterdam, Maastricht, and Utrecht ("The Netherlands"), Norwich (United Kingdom), Sabadell (Spain

212 ospitals (17 teaching and 2 academic) in the Netherlands (November 2014-September 2016), with a follo

213 Registry- and population-based study in the Netherlands of 15 527 patients aged 18 to 49 years with

214 h Heart Foundation, Dutch Federation of UMC, Netherlands OHRD and RNAS, German DFG, German BMBF, APH

215 OIBD) organized a workshop in Amsterdam, The Netherlands, on December 19(th) and 20(th), 2018 in an a

216 Crude data were analysed in the Netherlands, or analysed data were shared with the princ

217 ve primary DMEK procedures registered in the Netherlands Organ Transplant Registry were identified.

218 For more than 20 years, the Netherlands Organisation for Applied Scientific Research

219 insights into the methodology applied by the Netherlands Organisation for Applied Scientific Research

220 The Netherlands Organisation for Health Research and Develop

221 esearch Grant 2018, AMC PhD Scholarship, The Netherlands Organisation for Scientific Research (NWO),

222 rred moment of BCG administration.FUNDINGThe Netherlands Organization for Scientific Research, the Eu

223 , University Medical Center Utrecht, and the Netherlands Organization for Scientific Research.

224 ts with GBS admitted to hospitals across the Netherlands participating in national GBS studies from M

225 ngitudinal data analyses of cohorts from the Netherlands (Pediatric Rehabilitation Research in the Ne

226 ds (Pediatric Rehabilitation Research in the Netherlands; PERRIN) and Ontario, Canada (Adolescent Stu

227 Brazil, Canada, France, Germany, Italy, the Netherlands, Peru, Poland, Romania, Spain, and the USA,

228 he United Kingdom (ALSPAC) and 3652 from the Netherlands (PIAMA).

229 rom 5 European countries (France, Italy, the Netherlands, Poland, and the United Kingdom) who had bee

230 h Republic, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, and the UK) and four were no

231 enmark, Finland, France, Germany, Italy, the Netherlands, Poland, Spain, Sweden, Switzerland, the UK,

232 dy (TALENT) across 23 centres in Europe (the Netherlands, Poland, the UK, Spain, Bulgaria, Hungary, a

233 s large population-based cohort study in the Netherlands refutes the finding from a previous report t

234 l (age 0-89 days) invasive infections in the Netherlands reported between 1987 and 2016.

235 cluded were from Australia, Brazil, Ireland, Netherlands, Republic of Korea, United Kingdom, and USA.

236 a A(H5N8) viruses were reintroduced into the Netherlands, resulting in eight poultry farm outbreaks.

237 Denmark, Greece, Israel, Italy, Mexico, the Netherlands, Russia, the UK, and the USA.

238 tudy was done at 10 hospitals in Canada, the Netherlands, Scotland, and Australia.

239 ustralia, Canada, France, Greece, Italy, the Netherlands, Serbia, Spain, Sweden, Turkey, and the USA)

240 studies conducted in Australia, France, the Netherlands, Slovakia, and the UK were pooled along with

241 ical centres were enrolled in Italy, Latvia, Netherlands, Slovakia, UK, and the USA.

242 es (Belgium, Bulgaria, Finland, Ireland, the Netherlands, Slovenia, and the Navarra region in Spain)

243 23 hospitals across Belgium, Denmark, Italy, Netherlands, Slovenia, and United Kingdom in 2015-2018.

244 countries (Belgium, France, Germany, Poland, Netherlands, South Korea, Spain, the UK, and the USA).

245 public, France, Germany, Hungary, Japan, the Netherlands, South Korea, Spain, the UK, and the USA).

246 rgy and distributed across Germany, Ireland, Netherlands, Spain and UK via patient support groups.

247 sion phase from 15 hospitals in Belgium, the Netherlands, Spain, and the UK.

248 e recruited across 3 European countries: the Netherlands, Spain, and the United Kingdom.

249 e individuals in Europe (France, Greece, the Netherlands, Spain, Switzerland, and the UK) and North a

250 = 1792) were from two large cohort studies (Netherlands Study of Depression and Anxiety and Netherla

251 (n = 1925 and n = 1924, respectively) of the Netherlands Study of Depression and Anxiety.

252 In 2014 the Netherlands switched from 3 to 2 doses for routine vacci

253 tertiary heart valve centres in Germany, the Netherlands, Switzerland, and the UK.

254 Reports from the Netherlands, Switzerland, and the United Kingdom all sho

255 In the Netherlands the prevalence of intestinal Extended-spectr

256 d 2017 in the PHARMO Database Network in the Netherlands, the Danish population registers, and the IM

257 In the Netherlands, the first case of SARS-CoV-2 was notified o

258 glasshouse escapes in North America and the Netherlands, the invasive ladybird, Harmonia axyridis (P

259 In the Netherlands, the prevalence of intestinal extended-spect

260 France, Germany, Italy, Poland, Russia, the Netherlands, the UK, and the USA).

261 s (Brazil, China, Germany, Italy, Spain, the Netherlands, the UK, the USA, and Canada).

262 SIDETECT consortium study, from Germany, the Netherlands, the United Kingdom, and the United States.

263 e escalation and expansion study done in the Netherlands, the USA, Sweden, and Denmark.

264 ort studies from ten countries (Iceland, the Netherlands, the USA, Taiwan, the UK, Germany, Finland,

265 In the Netherlands, they attend quality assurance sessions.

266 tits (Parus major) in the United Kingdom and Netherlands to better understand how genetic signatures

267 s in the United States, New Zealand, and the Netherlands (total n = 2,332), to test whether factors t

268 ISS study is prospectively registered in the Netherlands Trial Register (NTR) since April 2019.

269 This trial was registered with the Netherlands Trial Register (NTR5689).

270 The Netherlands Trial Register NTR-7307.

271 Netherlands Trial Register, ID: NTR5436 (August 3, 2015)

272 Netherlands Trial Register, NL7083 , 06 July 2018.

273 The study is registered with The Netherlands Trial Registry (NTR1810) and EudraCT (2008-0

274 Netherlands Trial Registry Identifier: NTR2249.

275 in nursing home residents.Trial registration Netherlands Trial Registry NL6293.

276 nter nonblinded randomized controlled trial (Netherlands Trial Registry, NTR6023).

277 -wide association study was performed in the Netherlands Twin Register (N = 2258, mean age 37 years),

278 herlands Study of Depression and Anxiety and Netherlands Twin Register).

279 lation regions (DMRs) were identified in the Netherlands Twin Register, 19 in the Dunedin study, and

280 cluded six nonoverlapping DMRs (three in the Netherlands Twin Register, three in the Dunedin study) i

281 In the Netherlands, two strains (CMTV-NL I and III) were suspec

282 thern Caribbean (Lac Bay, Bonaire, Caribbean Netherlands) using genetic and demographic analyses.

283 tomy (MIE) was implemented nationally in the Netherlands, using data from the Dutch Upper GI Cancer A

284 icenter, randomized, controlled trial in the Netherlands, we assigned 40,373 women between the ages o

285 onducted between 2002 and 2006 in Rotterdam, Netherlands, we measured dialkyl phosphates (DAPs), OP m

286 ividuals on probation) from 2011-2012 in the Netherlands were followed up for violent and any reoffen

287 red squirrel (S. vulgaris) samples from the Netherlands were positive for the B. washoensis gltA gen

288 cruited from seven centres in the UK and the Netherlands were randomly assigned (1:1, using a compute

289 Models from Basel and The Netherlands were validated against repeated 24 h outdoor

290 ark, Cambridge [UK], Leicester [UK], and the Netherlands) were randomly assigned by computer-generate

291 ificantly decreased in recent decades in the Netherlands, where currently the greatest threat is cons

292 itive in 13% of patients with uveitis in the Netherlands, whereas only sporadic patients had a docume

293 versely, after the tram shooting in Utrecht, Netherlands (which was perpetrated by a Turkish-born imm

294 red during the drilling of a gas well in The Netherlands, which led to the uncontrolled release of la

295 ers decreased in the UK, Ireland, and in the Netherlands, while numbers were stable in Denmark.

296 mong young adults aged 18 to 49 years in the Netherlands who were 30-day survivors of first stroke, m

297 n the United Kingdom, France, Italy, and the Netherlands, who were enrolled in the European Soft Tiss

298 cents' Individual Lives Survey cohort in the Netherlands with measurements of up to 5 waves from age

299 erometric observations of lightning over the Netherlands with unprecedented spatiotemporal resolution

300 ranging from 0.69 for Italy to 0.88 for the Netherlands, with the sole exception of Ireland with a c